Scientific American

Weight and Health Benefits Vanish Fast after Quitting Weight-Loss Drugs, Study Finds

A new study finds that people who quit weight-loss medications including GLP-1s regain weight four times faster than people ...
STAT

Eli Lilly’s Zepbound, on top of immunology drug, helped reduce psoriatic arthritis symptoms

Eli Lilly said Thursday that adding its weight loss drug Zepbound on top of its immunology therapy Taltz helped obese ...

Lilly’s Zepbound plus Taltz boosts arthritis relief, weight loss in late-stage trial

Eli Lilly said on Thursday a late-stage trial showed its weight-loss drug Zepbound, used with its psoriatic arthritis ...
Fierce Pharma

Lilly touts promise of Zepbound-Taltz combo in patients with obesity and psoriatic arthritis

In an open-label phase 3b trial, the co-administration of Lilly’s IL-17A antagonist Taltz (ixekizumab) and dual GIP/GLP-1 ...